Call for Abstracts

With the registration of numerous novel therapies; the appearance of a number of generics; and the addition of Thalidomide and Bortezomib to the EML, access to innovative therapy is becoming a reality for many more South Africans than ever before. Haematology in South Africa is truly entering an exciting era. We want to use HaemOnc 2021 as an opportunity to embrace this, to get more people on board and further ignite the Haematology passion by hosting an exciting, world class conference, not only for Clinical Haematologists, but also for Students, Nursing staff, Oncologists, Pathologists or anyone that shares our Haematology passion.

Abstracts may be submitted online for Oral or Poster presentations and should be limited to 250 words.

Abstracts may be submitted in the following categories:

  • Clinical Haematology research
  • Laboratory Haematology research
  • Basic science research
  • Case presentation
  • Presentation by a non-profit organisation
  • Other – please specify
Important dates:

  • 20 August 2021: Abstract submission closes
  • 10 September 2021: Abstract resubmission closes
  • 30 September 2021: Abstract review process will be completed
  • 30 September 2021: Authors will be notified of their abstract status

Abstract Content

Please ensure that your abstract summarises your entire contribution in one paragraph (maximum of 250 words). Do not use section headings, but ensure that the content is structured.

Diagrams, illustrations, tables, references and graphics are NOT permitted.

Qualities of a good abstract embodies the following structure:

  • Uses an introduction-body-conclusion structure in which the parts of the report are discussed in order: purpose, research questions, methods, findings, conclusions, recommendations.
  • Can be understood without reading the paper.
  • Provides a condensed and concentrated version of the full paper.
  • Does not contain citations.
  • Does not contain lengthy background information.
  • Should contain actual research results and should not be a study/research protocol only.
  • Focus on the relevance, novelty and contribution to the field that the research is reporting.

These sections should briefly describe the objectives of the study or investigation, the basic procedures (study subjects and analytical methods), the main findings (giving specific data and the statistical significance, if possible), and the principal conclusion.